Your browser doesn't support javascript.
loading
Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial.
Barcenas, C H; Hurvitz, S A; Di Palma, J A; Bose, R; Chien, A J; Iannotti, N; Marx, G; Brufsky, A; Litvak, A; Ibrahim, E; Alvarez, R H; Ruiz-Borrego, M; Chan, N; Manalo, Y; Kellum, A; Trudeau, M; Thirlwell, M; Garcia Saenz, J; Hunt, D; Bryce, R; McCulloch, L; Rugo, H S; Tripathy, D; Chan, A.
Afiliação
  • Barcenas CH; The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: chbarcenas@mdanderson.org.
  • Hurvitz SA; University of California Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, USA.
  • Di Palma JA; University of South Alabama College of Medicine, Mobile, USA.
  • Bose R; Washington University School of Medicine, St Louis, USA.
  • Chien AJ; University of California San Francisco Comprehensive Cancer Center, San Francisco, USA.
  • Iannotti N; Hematology Oncology Associates of the Treasure Coast, Port St. Lucie, USA.
  • Marx G; Adventist Health Care, Wahroonga, Australia.
  • Brufsky A; Magee-Womens Hospital of UPMC, Pittsburgh, USA.
  • Litvak A; Saint Barnabas Medical Center, Livingston, USA.
  • Ibrahim E; Redlands Community Hospital, Redlands, USA.
  • Alvarez RH; Southeastern Regional Medical Center, Inc., Newnan, USA.
  • Ruiz-Borrego M; Hospital Universitario Virgen del Rocio, Sevilla, Spain.
  • Chan N; Rutger Cancer Institute of New Jersey, New Brunswick, USA.
  • Manalo Y; Coastal Bend Cancer Center, Corpus Christi, USA.
  • Kellum A; North Mississippi Medical Center Hematology and Oncology Clinic, Tupelo, USA.
  • Trudeau M; Sunnybrook Research Institute, Toronto, Canada.
  • Thirlwell M; McGill University Health Centre, Montreal, Canada.
  • Garcia Saenz J; Hospital Clínico San Carlos, Madrid, Spain.
  • Hunt D; Puma Biotechnology Inc., Los Angeles, USA.
  • Bryce R; Puma Biotechnology Inc., Los Angeles, USA.
  • McCulloch L; Puma Biotechnology Inc., Los Angeles, USA.
  • Rugo HS; University of California San Francisco Comprehensive Cancer Center, San Francisco, USA.
  • Tripathy D; The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Chan A; Breast Cancer Research Centre-WA & Curtin University, Perth, WA, Australia.
Ann Oncol ; 31(9): 1223-1230, 2020 09.
Article em En | MEDLINE | ID: mdl-32464281
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Neoplasias da Mama / Receptor ErbB-2 Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Neoplasias da Mama / Receptor ErbB-2 Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de publicação: Reino Unido